Home » DRUGMAKER CITA AIMS TO BE ACQUIRED, DELAYS IPO
DRUGMAKER CITA AIMS TO BE ACQUIRED, DELAYS IPO
August 16, 2005
Cita NeuroPharmaceuticals Inc. on Monday said it is in "advanced discussions" to be acquired by an international pharmaceutical company, prompting Cita to delay its initial public offering. Cita, a tiny drugmaker based in Mississauga, Ontario, said it hopes to reach a definitive agreement as quickly as possible to be acquired.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct